In Kidney Transplant Patients, Alemtuzumab but Not Basiliximab/Low-Dose Rabbit Anti-Thymocyte Globulin Induces B Cell Depletion and Regeneration, Which Associates with a High Incidence of De Novo Donor-Specific Anti-HLA Antibody Development
暂无分享,去创建一个
N. Perico | G. Remuzzi | F. Gaspari | P. Ruggenenti | E. Gotti | M. Noris | F. Casiraghi | M. Todeschini | A. Innocente | Monica Cortinovis | R. Cavinato | F. Poli | Annalisa Innocente